US FDA Authorized AffaMed’s Bispecific Biologic for Treating Retinal Vascular Diseases

The company ‘AffaMed Therapeutics’, a clinical stage biotechnology company that is dedicated to the commercialization and development of the transformative pharmaceutical, surgical and digital products announced that, the Food and Drug Administration (FDA) of the United States has now cleared the application of the Investigational New Drug (IND) for the clinical development of the AM712, […]

Continue Reading

US FDA Approves New Monoclonal Antibody That is Effective Against Omicron Variant

The Food and Drug Administration (FDA) of the United States have given the authorization for a new monoclonal antibody treatment that is working effectively against the Omicron covid-19 variant. The emergency use authorization for the bebtelovimab has been for the treatment of the mild to moderate corona virus in the adults and pediatric patients around […]

Continue Reading

US: Capsa Healthcare Acquired Humanscale Healthcare

Capsa Healthcare, leading innovator in the healthcare delivery solutions for long-term care, hospitals and the providers of the retail pharmacy announced that, it has acquired Humanscale Healthcare, which has been a producer and designer of the flexible technology solutions along computing the workstations based in the region of New York. This acquisition of Humanscale Healthcare […]

Continue Reading